PENDOPHARM is a rapidly growing and independent pharmaceutical business that focuses on commercializing a portfolio of specialty prescription products as well as a large and established line of OTC and BTC products.
Strategically committed to growth, PENDOPHARM is actively engaged in licensing, partnering, developing and marketing late-stage specialty prescription medicines as well as consumer brands.
PENDOPHARM – A Division of Pharmascience Inc.
PENDOPHARM is a division of Pharmascience Inc., a Canadian privately-owned company. Established in 1983, Pharmascience Inc. is the largest pharmaceutical company in Quebec, with a highly skilled workforce of 1,300 people. It commercializes nearly 300 products, including generic and branded prescription, OTC and BTC products. Pharmascience Inc. also has a significant international presence, with 25% of its $700 million annual sales coming from 60 countries.
